BusinessWire Archives - BAKX Therapeutics

November 16, 2022
BusinessWire

BAKX Welcomes Dr. Marina Konopleva to Its Scientific Advisory Board
read more
November 18, 2021
BusinessWire

BAKX Raises $25 Million to Develop Therapeutics Targeting Pro-Apoptotic Proteins and Mitochondrial Apoptosis Pathway
read more
July 27, 2021
BusinessWire

BAKX Therapeutics enters world-wide collaboration agreement with Ipsen for BKX-001
read more